BAKER BROS. ADVISORS LP
Q3 2025 13F Holdings
- Locationnew york, NY
- Num holdings
91
- Value ($000)
$13,838,782
- Date Filed11/14/2025
- Form type13F-HR
- CIK0001263508
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
BGNE BeOne Medicines Ltd. | SPONSORED ADS | 07725L102 | $3.00 B | 22 % | 8,799,053 | ||
INCY Incyte Corporation | COM | 45337C102 | $2.61 B | 19 % | 30,743,663 | ||
MDGL Madrigal Pharmaceuticals, Inc. | COM | 558868105 | $982.31 M | 7 % | 2,141,701 | ||
INSM Insmed Incorporated | COM PAR $.01 | 457669307 | $965.37 M | 7 % | 6,703,484 | ||
ACAD ACADIA Pharmaceuticals Inc. | COM | 004225108 | $915.42 M | 7 % | 42,896,690 | ||
SMMT Summit Therapeutics Inc. | COM | 86627T108 | $696.72 M | 5 % | 33,722,974 | ||
RYTM Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | $566.00 M | 4 % | 5,604,483 | ||
RVMD Revolution Medicines, Inc. | COM | 76155X100 | $441.57 M | 3 % | 9,455,357 | ||
CELC Celcuity Inc. | COM | 15102K100 | $391.04 M | 3 % | 7,915,792 | ||
KYMR Kymera Therapeutics, Inc. | COM | 501575104 | $376.47 M | 3 % | 6,651,429 |
Rows Per Page
10
- 10
- 50
- 100